However, we observed that Thbs1-knockdown MTO showed no significant difference in growth and metastatic formation in the splenic injection model (Supplementary Fig. 4b–g), suggesting no obvious contribution of tumor epithelium-derived THBS1 to tumor progression. The gene discussed is THBS1; the disease is neoplasm.